Back to all Laboratorio Reig Jofre S.A. press releases
Laboratorio Reig Jofre S.A.
- BME:RJF
REIG JOFRE reports Q1 2026 revenue decrease as EBITDA rises 1%
Published
At a glance
- Company
- Laboratorio Reig Jofre S.A.
- Listings
- BME:RJF
- Announcement type
- Financial results
- Published
- Reporting period
- Q1 2026
- Source announcement
- reigjofre.com
| Measure | Figure | Period | Compared with |
|---|---|---|---|
| Revenue | €86 million | Q1 2026 | –2% vs Q1 2025 |
| Gross margin | 60% | Q1 2026 | Not stated |
| Consolidated EBITDA | €10 million | Q1 2026 | +1% vs Q1 2025 |
| Consolidated net profit | €3 million | Q1 2026 | Not stated |
| Net financial debt | €102 million | Not stated | Not stated |
| NFD/EBITDA ratio | 3.3x | Not stated | Not stated |
Figures are quoted from this announcement and selected automatically.
FAQSIR Generated from this announcement View original release below for safe harbor and regulatory notices
This announcement is short enough to read in full, so FAQsIR has not summarised it.
Source announcement
- Company
- Laboratorio Reig Jofre S.A.
- Title
- REIG JOFRE publishes its Q1 2026 financial results
- Published
- Source site
- reigjofre.com
Read the source announcement on reigjofre.com
FAQSIR's summary and investor FAQs are generated by AI from the text of this announcement alone, without information from other sources.
Figures, forecasts and other claims are the announcement's, not FAQSIR's. FAQSIR does not independently verify them.
Read the original press release
Full text as published, unedited.